Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-11-08, Stock:JNJ, The news for the past five days is as follows:
2021-11-01: NEWS1: U.S. administers about 423 million doses of COVID-19 vaccines - CDC.NEWS2: Coronavirus: 'We have to be cautious' going into the winter season, doctor says.NEWS3: 11 Best Covid Vaccine and Pill Stocks To Invest In.NEWS4: J&J, Costco settle lawsuits over recalled sunscreen.NEWS5: 10 Stocks With Over 30 Years of Dividend Hikes.NEWS6: What Is the Nifty 50?.
2021-11-02: NEWS1: Democrats Reach Deal on Drug Prices, Schumer Says. Pharma Stocks Are Steady..NEWS2: Coronavirus: We must weigh the risk of vaccination for kids vs. risk of not getting the vaccine, doctor says.NEWS3: Is Johnson & Johnson a Good COVID Stock to Buy?.NEWS4: U.S. administers 423.9 mln doses of COVID-19 vaccines - CDC.NEWS5: 7 Stocks to Set Your Sights on as the ‘Hyperinflation’ Debate Stirs Up.NEWS6: Is J&J Stock A Buy On Its Bullish 2021 Forecast As Covid Booster Launches?.NEWS7: Why Teva Pharmaceutical Stock Is Jumping Today.NEWS8: Should Intuitive Surgical Investors Be Worried About Competition?.NEWS9: Johnson & Johnson, Costco Settle Lawsuits Over Recalled Sunscreen Products: Reuters.NEWS10: J&J, Teva Beat $50 Billion Opioid Case in First Industry Win.NEWS11: Opioid Manufacturers Score Win in California Lawsuit.NEWS12: UPDATE 2-California judge delivers drugmakers 1st trial win in opioid litigation.
2021-11-03: NEWS1: U.S. administers 425.3 mln doses of COVID-19 vaccines - CDC.NEWS2: COVID-19 vaccine has ‘an incredibly positive benefit to risk ratio’: Doctor.NEWS3: 10 Best Cancer Stocks To Buy Now.NEWS4: UPDATE 1-Italy recommends Pfizer or Moderna booster for those who had J&J shot.NEWS5: CDC recommends Pfizer COVID-19 vaccine for kids ages 5 to 11.NEWS6: Here's What Investors Need to Know About Johnson & Johnson's Q3 Earnings.NEWS7: Johnson & Johnson Launches a Health Equity Innovation Challenge in 6 U.S. Cities.NEWS8: Halozyme (HALO) Beats on Q3 Earnings, Tweaks 2021 Guidance.NEWS9: Italy recommends Pfizer or Moderna booster for those who had J&J shot.NEWS10: 11 Best Income Stocks To Buy Right Now.NEWS11: Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?.NEWS12: Covid Vaccines for Children Are Here. What to Know..
2021-11-04: NEWS1: Emergent BioSolutions, feds terminate long-running pandemic preparedness contract.NEWS2: RTP firm to coordinate study on Covid vaccines, autoimmune disease.NEWS3: 7 Stocks to Buy to Hone in on Ray Dalio’s Reliable Favorites.NEWS4: 7 Safe Stocks that are Immune from China’s Market Volatility.NEWS5: Theravance's (TBPH) Q3 Earnings Beat, Restructuring On Track.NEWS6: 10 Stocks To Buy Now According To Stamos Capital.
2021-11-05: NEWS1: J&J Renews Fight to Halt Baby Powder Suits Using Bankruptcy.NEWS2: Epidemiologist slams Aaron Rogers comments on COVID-19: 'It actually is a pandemic of the unvaccinated'.NEWS3: U.S. authorizes more batches of J&J COVID-19 vaccine made at Emergent.NEWS4: See Why Emergent BioSolutions Stock Plunged 37% On Friday?.NEWS5: 10 Dividend Stocks With Over 10% Yield.NEWS6: Here's Why Johnson & Johnson (JNJ) is a Strong Value Stock.NEWS7: FATE's Q3 Loss Narrower Than Expected, Pipeline in Focus.NEWS8: Emergent Tanks as U.S. Ends Contract, Vaccine Maker Cuts Outlook.NEWS9: Emergent Biosolutions shares tumble on news it will lose COVID vaccine production contract with govt'.NEWS10: Emergent BioSolutions Stock Plunges After Key Government Contract Terminated.NEWS11: Coronavirus tally: Global cases of COVID-19 top 248.7 million and U.S. cancels Emergent BioSolutions vaccine deal.NEWS12: The Novavax Rebound Is Just Warming Up.NEWS13: U.S. cancels multimillion dollar deal with Emergent BioSolutions, which produced contaminated J&J vaccines: report.NEWS14: 10 Stocks to Buy Under $15 According to Canadian Billionaire Prem Watsa.NEWS15: J&J fails in final bid to appeal Australian pelvic mesh class action ruling.NEWS16: J&J fails in final bid to appeal Australian pelvic mesh class action ruling.

Answer: Decrease